… : The second Nepal-China Pharmaceutical Conference has been successfully concluded … was focused on recent development in drug development, according to the organiser … to professors of different specialties, pharmacists, medical students and university …

… exhibit substantial pharmacodynamic and pharmacokinetic (PK) … al. Population pharmacokinetic/pharmacodynamic modeling for … pharmacokinetics and pharmacodynamics of remifentanil. I. Model development. … of a pharmacokinetic model developed for vancomycin …

… partnerships, and integrate pharmacovigilance into national health systems … and member states’ pharmacovigilance and immunisation programmes. … security and to developing robust systems for … sessions on harmonising pharmacovigilance terminology across member …

… and development platform, to the co-development. … selection to therapeutic development, identifying and characterizing … CEO of Secarna Pharmaceuticals. “From selecting the … Pharmaceuticals is a biopharmaceutical company redefining the discovery and development …

… Japan to expand pharmaceutical manufacturing and research.  … General of the Kansai Pharmaceutical Industries Association, and … representatives praised India’s pharmaceutical sector for its … for workforce development in Contract Development and Manufacturing …

CLN-978 led to rapid and deep B cell depletion in vitro and in vivo in multiple autoimmune diseases CAMBRIDGE, Mass., Oct. 25, 2025 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a clinical-stage biopharmaceutical company accelerating …

… enhance the efficiency of pharmaceutical and medical supply … and alignment with global developments in this vital sector. … regulatory bodies to develop the pharmaceutical oversight system and … for Egypt in the pharmaceutical sector, underscoring the …

… consultant for Phathom Pharmaceuticals. “This large, … patients who developed fundic gland polyps … Pharmaceuticals, Inc.  Phathom Pharmaceuticals is a biopharmaceutical company focused on the development … com © 2025 Phathom Pharmaceuticals. All rights reserved. …

… the collusion between Big Pharma, regulatory agencies and … obesity. Meanwhile, the pharmaceutical industry profits from treating … are further depleted by pharmaceutical drugs like statins. … incentives driving synthetic drug development. The fitness industry…

… all four canonical pharmacodynamic (PD) hallmarks … strong potency, excellent developability and ease of … pharmacology modelling, enabling detection of pharmacodynamic … analyses, including integrated pharmacokinetic-pharmacodynamic and circulating tumour …